Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 297.50
-5.80 (-1.91%)
Oct 23, 2026, 1:44 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 18.04 million as of October 23, 2026. It is the 44,168th most valuable company in the world and the 470th biggest in Israel. Its market cap has decreased by 64.78% in one year.
Market Cap
18.04M
Enterprise Value
-2.80M
Revenue
1.21M
Global Rank
Country Rank
#470 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 18.04M, a decrease of -74.06%. That is a compound annual growth rate of -7.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 18.04M | -77.04% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 210.26M |
| Matricelf | 81.24M |
| Clal Biotechnology Industries | 34.66M |
| BioLineRx | 32.86M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 27.20M |
| XTL Biopharmaceuticals | 19.87M |
| Evogene | 17.92M |